<DOC>
	<DOCNO>NCT00592488</DOCNO>
	<brief_summary>This placebo-controlled study investigate acetyl-L-carnitine treatment septic shock require vasopressor .</brief_summary>
	<brief_title>Acetyl-L-Carnitine Treatment Septic Shock</brief_title>
	<detailed_description>This cross-over study infuse ALC 12 18 hour ( placebo 6 ) . Patients must vasopressor-dependent septic shock free renal failure , hepatic failure , seizures eligible .</detailed_description>
	<mesh_term>Shock</mesh_term>
	<mesh_term>Shock , Septic</mesh_term>
	<mesh_term>Acetylcarnitine</mesh_term>
	<criteria>document presumed infection shock require vasopressor dialysis hepatic failure seizure</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2014</verification_date>
	<keyword>Septic shock</keyword>
	<keyword>Acetyl-L-carnitine</keyword>
</DOC>